-
Understanding Inducement Grants: A Look at Nektar Therapeutics’ Recent Disclosure
NASDAQ: $NKTR What Are Inducement Grants? In the world of corporate governance, transparency is key. Recently, Nektar Therapeutics (NASDAQ: NKTR) issued a formal report regarding the granting of equity awards to new employees. These types of transactions are often referred to as inducement grants. The Details Behind the Disclosure On August 29, 2019, Nektar Therapeutics…
-
Nektar Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
NASDAQ: $NKTR SAN FRANCISCO, Aug. 28, 2026 /PRNewswire/ — Nektar Therapeutics (NASDAQ: NKTR) today announced that, on August 20, 2026, the Organization and Compensation Committee of Nektar’s Board of Directors granted non-qualified stock options to purchase an aggregate of 25,200 shares of its common… Source: Read More